2018 Speaker Line Up
Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable knowledge share and facilitate idea exchange.
If you have a cutting edge case study or relevant presentation and would like to join the speaker panel at one of our events, please contact Cerlin Roberts on c.roberts@oxfordglobal.co.uk
Biomarkers & Precision Medicine USA Congress 2018 Speakers:
Stefan Scherer, Vice President, Global Head Correlative Science
Novartis
Alessandra Di Bacco, Senior Director, Translational Medicine
Takeda
Lars Bukhave Rasmussen, Vice President, Head of Marketing (Patient Solitions)
LEO Pharma Inc.
John Allinson, Vice President
BDS
Rajiv Raja, Director, Translational Sciences
MedImmune
Nuzhat Pathan, Director, Translational Oncology
Pfizer
Daniela Ennulat, Director of Pathology and Senior Science Fellow In Vitro In Vivo Translation
GlaxoSmithKline
Emmanuelle di Tomaso, Head of Translational Medicine
Syros
Katherine Call, Senior Director & Head, Proteogenomics Translational Sciences
Sanofi
Jane Wang, Director, TM CVMD, CVMD iMED
MedImmune/ AstraZeneca
Deepak Khatry, Science Associate Director, Statistical Sciences
MedImmune
Ernesto Munoz, Associate Director & Head of Biomarkers, Immunodermatology
Johnson & Johnson
Jennifer Burkey, Scientific Director, Predictive Safety Testing Consortium
Critical Path Institute
Dave Hoon, Director Molecular Oncology,
John Wayne Cancer Institute
Ken Chang, Director, Clinical Biomarkers
Daiichi Sankyo, Inc
Zhenhao Qi, Associate Director, Clinical Genetics & Genomics in Translational Medicine
Bristol-Myers Squibb
Elizabeth Somers, Director Diagnostics
Morphotek
Ajit Dash, Safety Science Associate Medical Director, Licensing and Early Development (LEAD) Safety – Non Oncology
Genentech
James Snider, Chief Scientific Officer and President
Critical Diagnostics
Robin Marsden, Associate Director, Bioanalytical
La Jolla Pharmaceutical Company
Stefan Kostense, Director Prevention Biomarker
Janssen
Pavan Kumar, Director of Biomarkers and Companion Diagnostics,
H3 Biomedicine
Nathan Hedrick, Director, Clinical Cytometry, CTTO, ECTR
Bristol-Myers Squibb
Tanja Zabka, Lead Safety Biomarker & Comparative Oncology Initiatives
Genentech
Allison Vitsky, Associate Research Fellow, Global Biomarkers, Drug Safety Research and Development
Pfizer
Mark Ma, Head of Biomarkers and Bioanalytics
Alexion
Xuemei Zhao, Senior Principal Scientist
Merck
Sheng Feng, Senior Principal Research Statistician
AbbVie
Keith Tanis, Principal Scientist, Genetics & Pharmacogenomics
Merck
Kevin Halling, Professor of Laboratory Medicine and Pathology
Mayo Clinic
Ronald M. Przygodzki, Director, Genomic Medicine Implementation, Associate Director, Genomic Medicine, Office of Research and Development
US Department of Veterans Affairs
Tony Jun Huang, Professor of Mechanical Engineering and Materials Science (MEMS) and Biomedical Engineering (BME)
Pratt School of Engineering, Duke University
John Nolan, Professor
Nolan Lab – Scintillon Institute
Follow us on